Predictive Model for Pain After TACE

Yantai Yuhuangding Hospital

Status: Completed

Conditions: Hepatocellular Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT05545046

2019-406

Details and patient eligibility

About

The main aim of this study was to analyze the risk factors that helped to predict the pain after transarterial chemoembolization (TACE).This was a prospective observational study enrolled all hepatocellular carcinoma (HCC) patients undergoing TACE in our hospital. Pain score at rest was assessed after TACE by the patients themselves using a Visual Analogue Scale (VAS). Independent variables such as age, gender, tumor location, tumor size and number, drug delivery method and presence of portal vein tumor thrombosis (PVTT) were recorded and analyzed.

Enrollment: 228 patients

Sex: All

Ages: 34 to 87 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A diagnosis of HCC was confirmed either histologically or based on consistent findings obtained from at least two imaging techniques.

Exclusion criteria

• patients aged < 18 year
• significant heart or lung dysfunction
• use of additional analgesics to relieve pain during TACE
• cognitive impairment
• use of psychiatric medications
• drug or alcohol abuse